However, 11 out of 25 patients were treated with tamoxifen, and it has been shown recently that chronic tamoxifen treatment does not alter PRL plasma levels in postmenopausal women with breast cancer (DeMarinis et al, 2000). Here, PRL is linked to breast carcinoma.